Publication | Open Access

Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody

Cancer ImmunosurveillanceCervical CancerImmunologyImmunoeditingPathologyCervical Carcinomas OverexpressImmunotherapyMedicineRadiation OncologyCell-surface MarkerCancer-associated Virus